KY HB346 | 2023 | Regular Session
Status
Spectrum: Partisan Bill (Republican 1-0)
Status: Introduced on February 16 2023 - 25% progression, died in committee
Action: 2023-02-16 - to Committee on Committees (H)
Pending: House Committee On Committees Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on February 16 2023 - 25% progression, died in committee
Action: 2023-02-16 - to Committee on Committees (H)
Pending: House Committee On Committees Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Amend KRS 304.17A-163 to permit insurers to require insureds to try biosimilar biological products prior to providing coverage for the equivalent branded prescription drug under certain circumstances; amend KRS 217.814 to define biosimilar biological product; amend KRS 217.822 to require dispensing of biosimilar biological products under certain circumstances.
Title
AN ACT relating to biosimilar medicines.
Sponsors
History
| Date | Chamber | Action |
|---|---|---|
| 2023-02-16 | House | to Committee on Committees (H) |
| 2023-02-16 | House | introduced in House |
Subjects
Kentucky State Sources
| Type | Source |
|---|---|
| Summary | https://apps.legislature.ky.gov/record/23RS/hb346.html |
| Text | https://apps.legislature.ky.gov/recorddocuments/bill/23RS/hb346/orig_bill.pdf |
